Gut Microbiota and Microbial Metabolites in the Regulation of Chemotherapeutic Resistance
Cells · 29.10.2026 · 15 (21) · 1975
DOI: 10.3390/cells15211975 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 29.10.2026. Verfasst von Shontol Bhowmic und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Chittaranjan National Cancer Institute (CNCI), Kolkata 700026, India. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drug Resistance, Neoplasm, Antineoplastic Agents, Neoplasms. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health Research (DHR), Government of India,, Department of Health Research (DHR), Government of India.
Abstract (Originalsprache)
Resistance to chemotherapy continues to be a significant challenge for cancer treatment and a contributing factor to treatment failures and tumor progression. Recently, the gut microbiome has emerged as an important modulator of the response to chemotherapy. Numerous pre-clinical and clinical studies have demonstrated a direct association between gut microbiota composition and therapy effectiveness in many cancer types, such as colorectal, breast, pancreatic, gastric, and lung cancers, melanoma, and hematological cancers. Gut microbiota effectively regulate the efficiency of chemotherapeutic agents in various ways, either by biotransformation of chemotherapeutic agents or modulation of host immunity. In addition, microbial metabolites such as short-chain fatty acids, secondary bile acids, and tryptophan metabolites are also involved in the regulation of chemotherapy response through modulating apoptosis, immunity, and epithelial–mesenchymal transition. Finally, dysbiosis induced by chemotherapy and antibiotics has also been reported to reduce the effectiveness of therapy. This review will emphasize the ways in which gut microbiota can modulate chemotherapeutic response and induce chemoresistance. Understanding the interactions between chemotherapeutic drugs and the gut microbiota can help to enhance the efficiency of chemotherapy and find more appropriate personalized treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, Chittaranjan National Cancer Institute (CNCI), Kolkata 700026, India.
- Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute (CNCI), Kolkata 700026, India.
- Department of Zoology, University of Calcutta, 35 Ballygunge Circular Road, Kolkata 700019, India.
ORCID-Profile: Shontol Bhowmic, Saptak Banerjee, Subir Kumar Juin, Sweta Ghosh
Förderung
- Department of Health Research (DHR), Government of India,
- Department of Health Research (DHR), Government of India
Zitieren
APA
Bhowmic, S., Roy Choudhury, P., Das, P., Banerjee, S., Chakrabarti, J., Juin, S. K., & Ghosh, S. (2026). Gut Microbiota and Microbial Metabolites in the Regulation of Chemotherapeutic Resistance. Cells, 15(21), 1975. https://doi.org/10.3390/cells15211975
Vancouver
Bhowmic S, Roy Choudhury P, Das P, Banerjee S, Chakrabarti J, Juin SK, et al. Gut Microbiota and Microbial Metabolites in the Regulation of Chemotherapeutic Resistance. Cells. 2026;15(21):1975. doi:10.3390/cells15211975
BibTeX
@article{Bhowmic2026,
author = {Bhowmic, Shontol and Roy Choudhury, Pritha and Das, Prodipto and Banerjee, Saptak and Chakrabarti, Jayanta and Juin, Subir Kumar and Ghosh, Sweta},
title = {Gut Microbiota and Microbial Metabolites in the Regulation of Chemotherapeutic Resistance},
journal = {Cells},
year = {2026},
volume = {15},
number = {21},
pages = {1975},
doi = {10.3390/cells15211975}
}
EUVIMED